High-Dose Statin Treatment Does Not Alter Plasma Marker for Brain Cholesterol Metabolism in Patients...
High-Dose Statin Treatment Does Not Alter Plasma Marker for Brain Cholesterol Metabolism in Patients With Moderately Elevated Plasma Cholesterol Levels
About this item
Full title
Author / Creator
Publisher
Oxford, UK: Blackwell Publishing Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Oxford, UK: Blackwell Publishing Ltd
Subjects
More information
Scope and Contents
Contents
Statins inhibit endogenous cholesterol synthesis, up‐regulate low‐density lipoprotein (LDL) receptor expression in mammalian liver cells, and thus decrease circulating LDL‐cholesterol concentrations. As cholesterol seems to play a role in the development of neurodegenerative diseases, it is of interest to evaluate the effect of high dosages of stat...
Alternative Titles
Full title
High-Dose Statin Treatment Does Not Alter Plasma Marker for Brain Cholesterol Metabolism in Patients With Moderately Elevated Plasma Cholesterol Levels
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_68600319
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68600319
Other Identifiers
ISSN
0091-2700
E-ISSN
1552-4604
DOI
10.1177/0091270006289851
